Display options
Share it on

J Endocr Soc. 2019 Mar 19;3(5):921-936. doi: 10.1210/js.2018-00414. eCollection 2019 May 01.

Anti-Müllerian Hormone Levels and Cardiometabolic Disturbances by Weight Status Among Men in the 1999 to 2004 National Health and Nutrition Examination Survey.

Journal of the Endocrine Society

Hind A Beydoun, Sharmin Hossain, May A Beydoun, Jordan Weiss, Alan B Zonderman, Shaker M Eid

Affiliations

  1. Department of Research Programs, Fort Belvoir Community Hospital, Fort Belvoir, Virginia.
  2. Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health Intramural Research Program, Baltimore, Maryland.
  3. Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.

PMID: 31020056 PMCID: PMC6469951 DOI: 10.1210/js.2018-00414

Abstract

CONTEXT: Serum anti-Müllerian hormone level (AMH) and body mass index may be jointly associated with cardiometabolic risk.

OBJECTIVES: Examine the contribution of AMH to cardiometabolic disturbances by weight status among US adult men.

DESIGN: Cross-sectional analysis using data from the 1999 to 2004 waves of the National Health and Nutrition Examination Survey.

SETTING: Multistage probability sampling of the noninstitutionalized US population.

PARTICIPANTS: US men aged ≥18 years. Final analytic sample sizes ranged from 517 to 1063 participants.

MAIN OUTCOME AND EXPOSURE MEASURES: Cardiometabolic disturbances (metabolic syndrome and its components, insulin resistance, diabetes, and chronic inflammation) and AMH were obtained from trained staff and nurses in a mobile examination center or during in-home visits.

RESULTS: AMH was directly associated with insulin resistance among obese men [OR 1.08 (95% CI 1.00, 1.15);

CONCLUSIONS: AMH was associated with specific cardiometabolic risk factors, including WC, diabetes status, and insulin resistance, in overweight and obese US men.

Keywords: anti-Müllerian hormone; diabetes; inflammation; insulin resistance; metabolic syndrome; obesity

References

  1. Am J Manag Care. 2002 Sep;8(11 Suppl):S283-92; quiz S293-6 - PubMed
  2. Arch Intern Med. 2004 May 24;164(10):1066-76 - PubMed
  3. Circulation. 2005 Oct 25;112(17):2735-52 - PubMed
  4. Hum Reprod. 2007 May;22(5):1200-9 - PubMed
  5. Minerva Endocrinol. 2007 Sep;32(3):129-40 - PubMed
  6. Ultrasound Q. 2007 Dec;23(4):233-8 - PubMed
  7. Fertil Steril. 2009 Dec;92(6):1966-82 - PubMed
  8. Dis Model Mech. 2009 May-Jun;2(5-6):231-7 - PubMed
  9. Endocr Rev. 2009 Aug;30(5):465-93 - PubMed
  10. Hum Reprod Update. 2010 Mar-Apr;16(2):113-30 - PubMed
  11. Obstet Gynecol. 2009 Oct;114(4):936-49 - PubMed
  12. Reprod Biomed Online. 2009 Oct;19(4):552-63 - PubMed
  13. Obes Facts. 2009;2(1):26-35 - PubMed
  14. Reproduction. 2010 May;139(5):825-33 - PubMed
  15. Curr Opin Endocrinol Diabetes Obes. 2010 Jun;17(3):247-56 - PubMed
  16. J Clin Endocrinol Metab. 2010 Sep;95(9):4258-67 - PubMed
  17. Arq Bras Cardiol. 2010 Sep;95(3):339-45 - PubMed
  18. J Card Fail. 2010 Aug;16(8):628-34 - PubMed
  19. Physiol Res. 2011;60(2):217-23 - PubMed
  20. Ann Clin Biochem. 2011 Jul;48(Pt 4):370-3 - PubMed
  21. Hormones (Athens). 2011 Apr-Jun;10(2):95-103 - PubMed
  22. PLoS One. 2011;6(7):e22024 - PubMed
  23. Reprod Health. 2011 Aug 17;8:24 - PubMed
  24. Hum Reprod. 2011 Nov;26(11):2925-32 - PubMed
  25. Mol Hum Reprod. 2012 Feb;18(2):79-87 - PubMed
  26. Nat Rev Endocrinol. 2012 Jan 10;8(6):331-41 - PubMed
  27. J Clin Endocrinol Metab. 2012 Jun;97(6):2160-3 - PubMed
  28. Int J Gynecol Cancer. 2012 Nov;22(9):1497-9 - PubMed
  29. J Diabetes Metab Disord. 2013 Jan 03;12(1):1 - PubMed
  30. J Endocrinol. 2013 Sep 06;219(1):13-20 - PubMed
  31. PLoS One. 2013 Aug 05;8(8):e70967 - PubMed
  32. Pediatr Diabetes. 2014 May;15(3):198-205 - PubMed
  33. Andrology. 2014 Mar;2(2):212-8 - PubMed
  34. J Family Community Med. 2013 Sep;20(3):179-86 - PubMed
  35. J Clin Endocrinol Metab. 2014 Sep;99(9):E1655-60 - PubMed
  36. Hum Reprod. 2015 Feb;30(2):493-4 - PubMed
  37. Pediatr Diabetes. 2016 May;17(3):184-90 - PubMed
  38. PLoS One. 2015 Jun 12;10(6):e0130210 - PubMed
  39. BMC Endocr Disord. 2015 Jul 25;15:35 - PubMed
  40. Adv Clin Chem. 2015;72:1-75 - PubMed
  41. Clin Endocrinol (Oxf). 2016 May;84(5):693-9 - PubMed
  42. Andrology. 2016 Sep;4(5):944-51 - PubMed
  43. Int J Cardiol. 2016 Nov 1;222:940-945 - PubMed
  44. J Clin Endocrinol Metab. 2017 Jan 1;102(1):33-39 - PubMed
  45. Climacteric. 2017 Dec;20(6):583-591 - PubMed
  46. Acta Diabetol. 2018 Aug;55(8):861-872 - PubMed
  47. Spine J. 2019 Feb;19(2):225-231 - PubMed
  48. BMJ Open Diabetes Res Care. 2018 Jul 23;6(1):e000535 - PubMed
  49. BMC Obes. 2018 Aug 6;5:21 - PubMed
  50. Adv Clin Chem. 2018;86:71-125 - PubMed
  51. Curr Vasc Pharmacol. 2018 Sep 03;:null - PubMed
  52. Clin Endocrinol (Oxf). 2019 Jan;90(1):145-154 - PubMed

Publication Types

Grant support